St. John's University, Jamaica, New York 11439, USA.
Rejuvenation Res. 2011 Apr;14(2):133-41. doi: 10.1089/rej.2010.1088. Epub 2011 Jan 5.
Hutchinson-Gilford progeria syndrome (HGPS) is a rare, deadly laminopathy. Research into its nature has provided valuable insights into understanding molecular mechanisms underlying cell senescence. Phenotypic changes in nuclear structure and heterochromatin, resulting from increased progerin production following overuse of a cryptic splice site in the LMNA gene have profound effects on cell cycle progression and DNA repair mechanisms. A high degree of genomic instability occurs as DNA double-strand breaks are introduced but not repaired, despite appropriate machinery. Damage-response mechanisms become deregulated as a result of failed recruitment of elongation factors and possibly ancillary to disruption of chromatin organization. Key regulatory regions on mRNA transcripts governing splicing activity have been exposed using antisense technology, and identification of novel molecular targets, such as xeroderma pigmentosum group A, have generated optimism for the possibility of finally yielding an effective therapy for slowing the aging process in HGPS patients while concomitantly providing valuable insights into physiological aging in general.
亨廷顿氏舞蹈症-早老综合征(HGPS)是一种罕见的、致命的核纤层蛋白病。对其本质的研究为理解细胞衰老的分子机制提供了有价值的见解。核结构和异染色质的表型变化是由于 LMNA 基因中隐藏剪接位点的过度使用导致 progerin 产生增加所致,这对细胞周期进程和 DNA 修复机制有深远影响。尽管存在适当的机制,但由于不能修复引入的 DNA 双链断裂,会发生高度的基因组不稳定性。由于伸长因子募集失败,损伤反应机制变得失调,可能与染色质组织的破坏有关。使用反义技术已经揭示了控制剪接活性的 mRNA 转录本上的关键调节区域,并且鉴定了新的分子靶标,如 XP 组 A,这为最终为 HGPS 患者减缓衰老过程提供有效治疗的可能性带来了乐观情绪,同时为一般的生理衰老提供了有价值的见解。